Sign In
Buy MRK
$115.49
+0.320 (+0.278%)
At Close: Jun 17, 2026
Should Invesco S&P Ultra Dividend Revenue ETF (RDIV) Be on Your Investing Radar?
10:20am, Tuesday, 23'rd Aug 2022 Zacks Investment Research
Style Box ETF report for RDIV
3 Biopharmas on Buyout Watch
12:00pm, Monday, 22'nd Aug 2022 The Motley Fool
These three biotech companies could be headed for a buyout soon.
What will insurance coverage of COVID-19 vaccines and treatments look like? The Biden administration is trying to figure that out
02:15pm, Sunday, 21'st Aug 2022 MarketWatch
Get ready for a big change in how the U.S. will pay for COVID-19 vaccines and treatments.
Ivermectin among generic drugs that failed to help COVID-19 patients avoid hospitalization, large study shows
02:10pm, Sunday, 21'st Aug 2022 MarketWatch
The New England Journal of Medicine trial showed fluvoxamine and metformin also had no impact stopping severe disease.
The Rise and Fall of Novavax
12:45pm, Sunday, 21'st Aug 2022 The Motley Fool
The story of Novavax stock over the last few years would make an amazing book.
Pharma Stock Roundup: End of SNY's Amcenestrant Development, FDA Updates for AZN, GSK
01:07pm, Friday, 19'th Aug 2022 Zacks Investment Research
Sanofi (SNY) ends the development of breast cancer candidate, amcenestrant. Novartis' (NVS) lung cancer candidate, canakinumab fails a phase III study. FDA grants priority review to AstraZeneca (AZN)
This Easy-to-Use Stock Strategy Is Crushing the Market
09:44am, Friday, 19'th Aug 2022 The Motley Fool
2022 has been a great year for a popular way to invest.
Democrats are wrong: Allowing Medicare to negotiate some drug prices won't be a game-changer
06:37pm, Thursday, 18'th Aug 2022 MarketWatch
Other parts of the new Inflation Reduction Act will have a bigger impact on seniors' healthcare costs.
What's in the Cards for Medtronic (MDT) in Q1 Earnings?
01:50pm, Thursday, 18'th Aug 2022 Zacks Investment Research
Going by the industry-wide macro trend, we expect Medtronic (MDT) to once again report an adverse effect related to the global supply chain issues in fiscal Q1.
Zacks Market Edge Highlights: Merck, PepsiCo, Honeywell, Microsoft and PNC Financial
08:40am, Thursday, 18'th Aug 2022 Zacks Investment Research
Merck, PepsiCo, Honeywell, Microsoft and PNC Financial have been highlighted in this Market Edge article.
The Story of the Greatest Mom and Pop Investor Ever
07:11pm, Wednesday, 17'th Aug 2022 Zacks Investment Research
Anne Scheiber grew $5,000 into $22 million over 50 years. How'd she do it?
Merck (MRK) Enters Into Circular RNA Collaboration With Orna
12:47pm, Wednesday, 17'th Aug 2022 Zacks Investment Research
Merck (MRK) is set to make an upfront payment of $150 million to Orna for rights to the latter's circular RNA technology to make vaccines and therapeutics for infectious disease and oncology.
Quest Diagnostics' (DGX) Base Volume Revives, New Ruling Aids
12:06pm, Wednesday, 17'th Aug 2022 Zacks Investment Research
With a bullish expectation for the remainder of 2022, Quest Diagnostics (DGX) raises its full-year guidance.
Merck (MRK) Enters Into Circular RNA Collaboration With Orna
10:32am, Wednesday, 17'th Aug 2022
Merck (MRK) is set to make an upfront payment of $150 million to Orna for rights to the latter's circular RNA technology to make vaccines and therapeutics for infectious disease and oncology.
Here's Why You Should Retain Thermo Fisher (TMO) Stock Now
04:36pm, Tuesday, 16'th Aug 2022 Zacks Investment Research
Investors are optimistic about Thermo Fisher's (TMO) better-than-expected results and robust international performance.
